Literature DB >> 9527483

Mycobacterial phagosome maturation, rab proteins, and intracellular trafficking.

V Deretic1, L E Via, R A Fratti, D Deretic.   

Abstract

One of the most prominent features of pathogenic mycobacteria, which include the potent human pathogens Mycobacterium tuberculosis and Mycobacterium leprae and their opportunistic relatives Mycobacterium avium and Mycobacterium marinum, is their ability to survive and multiply in phagosomes of mononuclear phagocytic cells. The phagocytosed mycobacteria reside in a vacuolar compartment which is exempted from maturation into the phagolysosome. Recently, the arrest of the maturation of phagosomes containing M. tuberculosis complex organisms (Mycobacterium bovis BCG) has been linked to the accumulation on the phagosomal membrane of the small GTP binding protein rab5, specific for the control of fusion within the early endosomal compartment. Furthermore, M. bovis BCG phagosome is devoid of rab7, a rab protein associated with the late endosome. The selective accumulation of rab5 and exclusion of rab7 defines the check point that has been compromised in mycobacterial phagosome maturation. Here we summarize these observations and relates them to other phenomena in the area of membrane and protein trafficking with the emphasis on phagosomes containing intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9527483     DOI: 10.1002/elps.1150181409

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  24 in total

Review 1.  Bugs as drugs for cancer.

Authors:  Eleanor J Cheadle; Andrew M Jackson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

2.  Modulation of phagolysosome maturation by bacterial tlyA gene product.

Authors:  Ekansh Mittal; Santosh Kumar; Aejazur Rahman; Musti V Krishnasastry
Journal:  J Biosci       Date:  2014-12       Impact factor: 1.826

3.  Identification of two Mycobacterium tuberculosis H37Rv ORFs involved in resistance to killing by human macrophages.

Authors:  B H Miller; T M Shinnick
Journal:  BMC Microbiol       Date:  2001-10-17       Impact factor: 3.605

4.  Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum.

Authors:  E Pagán-Ramos; J Song; M McFalone; M H Mudd; V Deretic
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

Review 5.  n-3 Fatty acids uniquely affect anti-microbial resistance and immune cell plasma membrane organization.

Authors:  David N McMurray; Diana L Bonilla; Robert S Chapkin
Journal:  Chem Phys Lipids       Date:  2011-07-20       Impact factor: 3.329

6.  Incorporation of a dietary omega 3 fatty acid impairs murine macrophage responses to Mycobacterium tuberculosis.

Authors:  Diana L Bonilla; Lan H Ly; Yang-Yi Fan; Robert S Chapkin; David N McMurray
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

7.  Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection.

Authors:  Barbara H Miller; Rutilio A Fratti; Jens F Poschet; Graham S Timmins; Sharon S Master; Marcos Burgos; Michael A Marletta; Vojo Deretic
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  The metabolic activity of Mycobacterium tuberculosis, assessed by use of a novel inducible GFP expression system, correlates with its capacity to inhibit phagosomal maturation and acidification in human macrophages.

Authors:  Bai-Yu Lee; Daniel L Clemens; Marcus A Horwitz
Journal:  Mol Microbiol       Date:  2008-03-19       Impact factor: 3.501

9.  Activation of macrophages and interference with CD4+ T-cell stimulation by Mycobacterium avium subspecies paratuberculosis and Mycobacterium avium subspecies avium.

Authors:  Susanne Zur Lage; Ralph Goethe; Ayub Darji; Peter Valentin-Weigand; Siegfried Weiss
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

10.  MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.

Authors:  Anda Meierovics; Wei-Jen Chua Yankelevich; Siobhán C Cowley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.